Van Hulzen Asset Management LLC Invests $452,000 in HealthEquity, Inc. $HQY

Van Hulzen Asset Management LLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 5,000 shares of the company’s stock, valued at approximately $452,000.

A number of other institutional investors have also recently made changes to their positions in HQY. BlackRock Inc. acquired a new position in shares of HealthEquity during the second quarter valued at about $1,018,621,000. William Blair Investment Management LLC acquired a new stake in HealthEquity in the 4th quarter worth approximately $169,956,000. Wasatch Advisors LP boosted its stake in HealthEquity by 10.5% in the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after purchasing an additional 757,801 shares in the last quarter. Norges Bank purchased a new stake in HealthEquity during the 4th quarter worth approximately $66,927,000. Finally, Bank of New York Mellon Corp purchased a new stake in HealthEquity during the 2nd quarter worth approximately $60,177,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Citizens Jmp upped their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. BTIG Research raised their target price on HealthEquity from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Finally, Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Price Performance

NASDAQ:HQY opened at $105.39 on Wednesday. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The firm has a market cap of $8.81 billion, a price-to-earnings ratio of 39.47, a PEG ratio of 1.77 and a beta of 0.21. The firm’s fifty day moving average is $97.41 and its two-hundred day moving average is $87.53.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insider Buying and Selling

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the sale, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. The trade was a 4.31% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock valued at $1,651,280 over the last ninety days. Company insiders own 1.60% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.